The Prezista 400mg tablets are licensed for use with low dose ritonavir in combination with other antiretrovirals for the treatment of HIV in antiretroviral naïve patients.
The 600mg tablets, along with the existing 300mg tablets, are available for the treatment of HIV with low dose ritonavir in combination with other antiretrovirals, in treatment experienced adult patients, including those that have been highly pre-treated. The Prezista 600mg tablet has been launched to reduce patients' pill burden.
The recommended dosage in treatment naive patients is 800mg once daily with ritonavir 100mg once daily.
Further information: Janssen-Cilag